 |
4,6,8-trihydroxy-10-(3,7,11-trimethyldodeca-2,6,10-trienyl)-5,10-dihydrodibenzo b,e][1,4]diazepin-11-one |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2009-04-27 00:00:00 |
| Sponsor | Thallion Pharmaceuticals, Inc.;7150 Alexander-Fleming; |
Related Access Program